About Us
- Overview
- History
- Mission
- Team
- Contact Us
Our Science
- Our FoCus
- Our Publications
Pipeline
Partnerships
Press Release
- Press Release
- Media Coverage
Join Us
Legal Notice
Privacy Policy

Jun，2024

Categories: History

Time of issue:2025-01-14 14:51

Released Positive Phase Ib/II Results for Ifebemtinib in Combination with Garsorasib in 1L NSCLC with KRAS G12C Mutation

Prev: Oct，2024

Next: Dec，2023

QUICK LINKS

About Us
- Overview
- History
- Mission
- Team
- Contact Us
Our Science
- Our FoCus
- Our Publications
Pipeline
Partnerships
Press Release
- Press Release
- Media Coverage
Join Us
Legal Notice
Privacy Policy

Tel: +86 25-58251030
Email: office@inxmed.com
Office address: 73 Tanmi Road Block D-2, 3rd Floor Jiangbei New District, Nanjing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

MESSAGE

SEO